Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

13.29
-0.0600-0.45%
Volume:819.93K
Turnover:10.93M
Market Cap:2.00B
PE:-2.97
High:13.62
Open:13.33
Low:13.04
Close:13.35
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:0.52
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:163.56
PE(LYR):-1.94

Loading ...

Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2024

Major Issues Report

Form 8-K - Current report
Apr 22, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals